All Stories

  1. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up
  2. Personalized Treatment of Mothers With ADHD and Their Young At-Risk Children: A SMART Pilot
  3. Advancing Regulatory Science
  4. Sleep habits in children with attention-deficit/hyperactivity disorder predominantly inattentive type and associations with comorbid psychopathology symptoms
  5. Commentary: Does helping mothers with ADHD in multiplex families help children? Reflections on Jans et al. (2015)
  6. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial
  7. Feedback associated with expectation for larger-reward improves visuospatial working memory performances in children with ADHD
  8. New Research on the Complex Interaction of Sleep and ADHD
  9. Integration of an EEG biomarker with a clinician's ADHD evaluation
  10. Functional neuroimaging of visuospatial working memory tasks enables accurate detection of attention deficit and hyperactivity disorder
  11. Dopamine Transporter Genotype and Stimulant Dose-Response in Youth with Attention-Deficit/Hyperactivity Disorder
  12. The war on ADHD
  13. Sleep Problems and Interventions in Preschoolers with ADHD
  14. Randomized, Double-Blind Trial of Guanfacine Extended Release in Children With Attention-Deficit/Hyperactivity Disorder: Morning or Evening Administration
  15. Assessment and Management of Sleep Problems in Youths With Attention-Deficit/Hyperactivity Disorder
  16. Pharmacotherapy for Parents with Attention-Deficit Hyperactivity Disorder (ADHD)
  17. Variable sleep schedules and outcomes in children with psychopathological problems: preliminary observations
  18. Dose Effects and Comparative Effectiveness of Extended Release Dexmethylphenidate and Mixed Amphetamine Salts
  19. Effects of Maternal Stimulant Medication on Observed Parenting in Mother–Child Dyads With Attention-Deficit/Hyperactivity Disorder
  20. Dose–Response Characteristics in Adolescents with Attention-Deficit/Hyperactivity Disorder Treated with OROS ® Methylphenidate in a 4-Week, Open-Label, Dose-Titration Study
  21. Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics
  22. Pharmacogenomics of Attention-Deficit/Hyperactivity Disorder
  23. Increased Cortisol after Stress is Associated with Variability in Response Time in ADHD Children
  24. Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder
  25. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder
  26. Dopamine Transporter Genotype and Stimulant Side Effect Factors in Youth Diagnosed with Attention-Deficit/Hyperactivity Disorder
  27. The Pharmacogenomic Era: Promise for Personalizing Attention Deficit Hyperactivity Disorder Therapy
  28. Maternal Depression Predicts Maternal Use of Corporal Punishment in Children with Attention-Deficit / Hyperactivity Disorder
  29. ADHD By Night: Sleep Problems and ADHD Medications
  30. ADHD Pharmacogenomics: Past, Present, and Future
  31. Cortisol is inversely correlated with aggression for those boys with attention deficit hyperactivity disorder who retain their reactivity to stress
  32. Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects
  33. Once-Daily OROS ® Methylphenidate Is Safe and Well Tolerated in Adolescents With Attention-Deficit/Hyperactivity Disorder
  34. Medical Mimics
  35. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder
  36. ADHD Treatment With Once-Daily OROS Methylphenidate: Final Results From a Long-Term Open-Label Study
  37. Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD
  38. Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder
  39. ADHD Treatment With Once-Daily OROS Methylphenidate: Interim 12-Month Results From a Long-Term Open-Label Study
  40. Sex Differences in Young Children Who Meet Criteria for Attention Deficit Hyperactivity Disorder
  41. Sex Differences in Young Children Who Meet Criteria for Attention Deficit Hyperactivity Disorder
  42. Newborn thyroxine levels and childhood ADHD
  43. Can Stimulant Rebound Mimic Pediatric Bipolar Disorder?
  44. Dexmethylphenidate
  45. WISC-III THIRD FACTOR
  46. EVALUATION OF ADULTS FOR ADHD
  47. Comorbidity and Gender Differences in ADHD
  48. Anthropometrics and ADHD: "Lean and Mean" No More?
  49. Feasibility of Identifying and Treating School Problems in Primary Care: Early Experiences and Lessons Learned
  50. Sleep Problems in Children: Relationship with Psychopathology and Pharmacotherapy
  51. The Third Factor of the WISC-III: It's (Probably) Not Freedom From Distractibility
  52. Unravelling Sleep Problems in Treated and Untreated Children with ADHD
  53. ANTHROPOMETRICS AND ADHD: IS THERE AN ASSOCIATION? 84
  54. Eye Manifestations of Congenital Toxoplasmosis
  55. IS ADHD SOCIAL DISABILITY REALLY COMORBIDITY?
  56. Eye Manifestations of Congenital Toxoplasmosis
  57. Attention-Deficit Hyperactivity Disorder in Adults (Book)
  58. UNDERDIAGNOSIS AND OVERDIAGNOSIS OF ADHD: DIAGNOSTIC ACCURACY OF BEHAVIORAL RATINGS AND UTILITY OF PSYCHOMETRIC TESTING. 109
  59. Behavioral and Cognitive Effects of Methylxanthines
  60. Neurocognitive Characteristics of Individuals with Resistance to Thyroid Hormone
  61. Attention deficit hyperactivity disorder and whole-blood serotonin levels: effects of comorbidity
  62. Adaptive Skills Dysfunction in ADD and ADHD Children
  63. Adaptive Skills Dysfunction in ADD and ADHD Children
  64. Psychometric properties of the children's atypical development scale
  65. Dexamethasone Suppression and Childhood Depression: Association with Categorical and Dimensional Measures
  66. Attention-deficit hyperactivity disorder and thyroid function
  67. Book Reviews
  68. Classification of children's behavior problems: Clinical and quantitative approaches
  69. Behavioral validity of a brief teacher rating scale (the AML) in identifying high-risk acting-out schoolchildren
  70. Basic and clinical research on Attention Deficit Hyperactivity Disorder (ADHD)
  71. Mimics of ADHD
  72. Assessment of ADHD in children and adolescents